Search published articles


Showing 2 results for Chitosan

Zahra Sadat Mirei, Minoo Sadri, Ali Salimi,
Volume 3, Issue 3 (12-2016)
Abstract

Main agent orange-red coloured pigment of henna is a molecule called Lawson which is responsible for anti-microbial, anti-tumor, anti-inflammatory and analgesic activity. Chitosan is a biopolymer with high strength, biocom-patibility and biodegradability, non-toxicity and antimicrobial properties. Electrospinning is a method of producing su-bmicron polymeric fibers with high porosity and high surface/volume ratio. In this study, electrospinning of chitos-an/polyethylene oxide (Chit/PEO) nanofibers with the addition of henna extract to create nanofibers with antimicrobial properties were examined. Nanofibers was constructed by electrospinning of polymeric solution with proper size and si-ze distribution of Chit/PEO with a ratio 90/10. Then, Lawsonia inermis (henna) extract as an additive to Chit/PEO co-polymer was added and electrospined on the surface. After characterization of nanofibers using SEM, the antimicrobial properties of polymeric solution and nanofibers were investigated. The scanning electron micrographs showed that Ch-it/PEO nanofibres with a low percentage of henna extract have suitable diameters and size distribution similar to Ch-it/PEO nanofibres without adding extract. In bacteriological studies, it was found that chitosan polymer solutions cont-aining 1% of henna extract has bactericidal properties against Staphylococcus aureus, Escherichia coli and Pseudo-monas aeruginosa bacteries better than polymer chitosan solution without adding the extract.


Nina Alizadeh, Shokufeh Malakzadeh,
Volume 8, Issue 2 (7-2021)
Abstract

The aim of this study was to investigate the interaction modification of curcumin complex molecule (CUR) in beta- and gamma-cyclodextrin (β-CD and γ-CD) carriers with chitosan (CS) nanoparticles for targeted drug delivery and to compare their performance. The targeted drug delivery system includes the therapeutic agent of the CS nanoparticles targeting section of the same drug and the CD carrier system. Calculations of the relationships of the formation of modified complexes and their application were performed using UV-vis spectroscopic data analysis. In this study, spectroscopic spectrum diagrams were drawn to prove the optimization of molecular structure in the modified complexes. Data analysis was performed using their respective equations. The cationic polysaccharide CS, with the presence of amino agents and alcohols along the polysaccharide chains, enables it to form a covalent bond with the complexes and increase the solubility of cyclodextrin. CS nanoparticles strengthen the hydrogen bond by hydrogen bonding and van der Waals hydrogen interactions of the hydroxyl cyclodextrin group with the hydroxyl phenolic group of the drug molecule CUR. Modification of the γ-CD complex with CS shows the strongest interaction with CUR. Both CUR complexes are in the CD-CS host system to transfer the charge from the drug to the carrier and the therapeutic agent. CS nanoparticles have the property of targeted delivery systems for anticancer drugs because the CS external field can be used to direct the drug to specific target cells. The γ-CD-CS host system is the best host as a carrier and therapeutic agent for CUR due to its high solubility and strong interaction.
 
 

Page 1 from 1     

Creative Commons Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



© 2024 CC BY-NC 4.0 | Nova Biologica Reperta

Designed & Developed by : Yektaweb